Total
(
n
=
210, 100%
)
Placebo
(
n
=
103, 49.0%
)
AGE Treatment
(
n
=
107, 51.0%
)
P
-value
Age, years
58.3 ± 8.5
57.7 ± 8.8
59.0 ± 8.2
0.25
Female,
n
(%)
38 (18.1)
18 (17.5)
20 (18.7)
0.81
Statin,
n
(%)
76 (45.5)
40 (50.0)
36 (41.4)
0.26
CACs Progression Ratio
§
15.6 (0.9, 32.8)
18.3 (3.1, 34.0)
10.8 (0.0, 31.6)
0.0325
*
There is no significant difference between the treatment groups with regard to age, gender, or statin use. Data presented as Median (Quartile 1, Quartile 3),
p
-value from median test.
Table 1:
Clinical Risk Factor Distribution by Treatment Group.
